WEBB MICHAEL D 4
4 · EPIX Pharmaceuticals, Inc. · Filed Oct 25, 2004
Insider Transaction Report
Form 4
WEBB MICHAEL D
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2004-10-21$0.45/sh+2,160$980→ 41,412 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-21$16.25/sh−2,160$35,100→ 39,252 total - Sale
Common Stock (Sale Pursuant to a 10b5-1 Trading Plan)
2004-10-21$16.25/sh−340$5,525→ 38,912 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-10-21$0.45/sh+2,160$980Exercise: $0.45From: 1999-12-16Exp: 2004-12-16→ Common Stock (2,160 underlying)
Footnotes (2)
- [F1]Reporting person indirectly owns 2,500 shares of common stock through his spouse.
- [F2]From December 16, 1994 grant of 330,467 options to purchase shares of common stock of which 302,326 options have been exercised and the remaining 32,461 options are currently exercisable.